We are live on ! Find out more
INVA icon

Innoviva

218 hedge funds and large institutions have $1.17B invested in Innoviva in 2022 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 91 increasing their positions, 76 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

921% more call options, than puts

Call options by funds: $2.47M | Put options by funds: $242K

20% more repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 76

2.46% more ownership

Funds ownership: 110.42%112.88% (+2.5%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

8% less funds holding

Funds holding: 236218 (-18)

21% less capital invested

Capital invested by funds: $1.49B → $1.17B (-$319M)

33% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 33

Holders
218
Holders Change
-18
Holders Change %
-7.63%
% of All Funds
3.66%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
22
Increased
91
Reduced
76
Closed
33
Calls
$2.47M
Puts
$242K
Net Calls
+$2.23M
Net Calls Change
+$587K

INVA Hedge Fund Activity: Q2 2022 in Review

218 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q2 2022, worth a combined $1.17B — down 21% from $1.49B a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of INVA and 22 opened new positions — a net loss of 11 holders — while 76 trimmed existing stakes and 91 added.

The largest buyer was BlackRock, adding an estimated $18.2M. The largest seller was Nomura Holdings, cutting an estimated $22.4M.

  • 218 institutional investors held Innoviva (INVA) as of Q2 2022, down from 236 in Q1 2022.
  • Funds reported $1.17B of Innoviva stock for Q2 2022, down 21% quarter-over-quarter.
  • 22 funds opened new Innoviva positions in Q2 2022 and 33 closed out, a net change of -11 holders.
  • The largest Innoviva buyer in Q2 2022 was BlackRock, an estimated $18.2M added.
  • The largest Innoviva seller in Q2 2022 was Nomura Holdings, an estimated $22.4M sold.

Based on aggregated 13F filings for Q2 2022.